Kun patienter med klar fremskreden nyrecellecancer og lav og mellem risiko MSKCC (Memorial Sloan Kettering Cancer Center) var inkluderet.
Only patients with clear cell renal carcinoma and low and intermediate risk MSKCC (Memorial Sloan Kettering Cancer Center) were included.